HOFSETH BIOCARE ASAHOFSETH BIOCARE ASAHOFSETH BIOCARE ASA

HOFSETH BIOCARE ASA

No trades
See on Supercharts
Market capitalization
‪869.18 M‬NOK
−0.27NOK
‪−106.68 M‬NOK
‪190.82 M‬NOK
‪180.21 M‬
Beta (1Y)
0.52

About HOFSETH BIOCARE ASA

Headquarters
Ålesund
Founded
2009
ISIN
NO0010598683
FIGI
BBG003FWLJ29
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. Its products include ProGo Bioactive Peptides, OmeGo Salmon Oil, CalGo Calcium Collagen Complex, and Shop Branded Products. The company was founded by Roger Hofseth in 2000 and is headquartered in Alesund, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of HBCO is 2.08 NOK — it has decreased by 0.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange HOFSETH BIOCARE ASA stocks are traded under the ticker HBCO.
HOFSETH BIOCARE ASA is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
HBCO stock is 0.48% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is HOFSETH BIOCARE ASA there?
Yes, you can track HOFSETH BIOCARE ASA financials in yearly and quarterly reports right on TradingView.
HBCO stock has fallen by 0.95% compared to the previous week, the month change is a 7.14% fall, over the last year HOFSETH BIOCARE ASA has showed a 40.57% decrease.
HBCO net income for the last quarter is ‪−51.89 M‬ NOK, while the quarter before that showed ‪−22.72 M‬ NOK of net income which accounts for −128.46% change. Track more HOFSETH BIOCARE ASA financial stats to get the full picture.
Today HOFSETH BIOCARE ASA has the market capitalization of ‪869.18 M‬, it has increased by 1.00% over the last week.
No, HBCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HBCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HOFSETH BIOCARE ASA stock right from TradingView charts — choose your broker and connect to your account.
HBCO reached its all-time high on Nov 26, 2019 with the price of 10.80 NOK, and its all-time low was 1.22 NOK and was reached on Feb 16, 2017.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HOFSETH BIOCARE ASA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HOFSETH BIOCARE ASA stock shows the sell signal. See more of HOFSETH BIOCARE ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HOFSETH BIOCARE ASA EBITDA is ‪−90.75 M‬ NOK, and current EBITDA margin is −47.04%. See more stats in HOFSETH BIOCARE ASA financial statements.